Kathleen M. Grubbs

Dr. Kathleen M. Grubbs


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Psychiatric Services
Verified
Journal Article
Closed access
KGKathleen M. Grubbs
Kathleen M. Grubbs
ACAnn M. Cheney
Ann M. Cheney
JFJohn C. Fortney
John C. Fortney
CECarrie Edlund
Carrie Edlund
XHXiaotong Han
Xiaotong Han
JSJ. Greer Sullivan
J. Greer Sullivan

1 December 2015 in Journal of Traumatic Stress
Verified
Journal Article
Closed access
PDF file
KGKathleen M. Grubbs
Kathleen M. Grubbs
JFJohn C. Fortney
John C. Fortney
JPJeffrey M. Pyne
Jeffrey M. Pyne
THTeresa Hudson
Teresa Hudson
WMWilliam Mark Moore
William Mark Moore
PSPaula P. Schnurr
Paula P. Schnurr

23 January 2017 in The Journal of Rural Health
Verified
Journal Article
Closed access
PDF file
KGKathleen M. Grubbs
Kathleen M. Grubbs
JFJohn C. Fortney
John C. Fortney
TKTim Kimbrell
Tim Kimbrell
JPJeffrey M. Pyne
Jeffrey M. Pyne
THTeresa Hudson
Teresa Hudson
PSPaula P. Schnurr
Paula P. Schnurr

1 September 2019 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
LMLeslie A. Morland
Leslie A. Morland
AMAlexandra Macdonald
Alexandra Macdonald
KGKathleen M. Grubbs
Kathleen M. Grubbs
MMMargaret-Anne Mackintosh
Margaret-Anne Mackintosh
CMCandice Monson
Candice Monson
SGShirley Glynn
Shirley Glynn
Interpersonal difficulties are common among veterans with posttraumatic stress disorder (PTSD) and are associated with poorer treatment response. Treatment outcomes for PTSD, including relationship functioning, improve when partners are included and engaged in the therapy process. Cognitive-behavioral conjoint therapy for PTSD (CBCT) is a manualized 15-session intervention designed for couples in which one partner has PTSD. CBCT was developed specifically to treat PTSD, engage a partner in treatment, and improve interpersonal functioning. However, recent research suggests that an abbreviated CBCT protocol may lead to sufficient gains in PTSD and relationship functioning, and yield lower dropout rates. Likewise, many veterans report a preference for receiving psychological treatments through clinical videoteleconferencing (CVT) rather than traditional face-to-face modalities that require travel to VA clinics. This manuscript describes the development and implementation of a novel randomized controlled trial (RCT) that examines the efficacy of an abbreviated 8-session version of CBCT ("brief CBCT," or B-CBCT), and compares the efficacy of this intervention delivered via CVT to traditional in-person platforms. Veterans and their partners were randomized to receive B-CBCT in a traditional Veterans Affairs office-based setting (B-CBCT-Office), CBCT through CVT with the veteran and partner at home (B-CBCT-Home), or an in office-delivered, couple-based psychoeducation control condition (PTSD Family Education). This study is the first RCT designed to investigate the delivery of B-CBCT specifically to veterans with PTSD and their partners, as well as to examine the delivery of B-CBCT over a CVT modality; findings could increase access to care to veterans with PTSD and their partners.

1 April 2018 in Psychiatric Services
Verified
Journal Article
Closed access
KGKathleen M. Grubbs
Kathleen M. Grubbs
JFJohn C. Fortney
John C. Fortney
JPJeffrey Pyne
Jeffrey Pyne
DMDinesh Mittal
Dinesh Mittal
JRJohn Ray
John Ray
THTeresa J. Hudson
Teresa J. Hudson

13 July 2022 in Contemporary Clinical Trials
Verified
Journal Article
Open access
KBKeith Bredemeier
Keith Bredemeier
SLSadie Larsen
Sadie Larsen
GSGeetha Shivakumar
Geetha Shivakumar
KGKathleen M. Grubbs
Kathleen M. Grubbs
CMCarmen McLean
Carmen McLean
MTMichael Thase
Michael Thase
Several efficacious psychological and pharmacological treatments for posttraumatic stress disorder (PTSD) are available; however, the comparative effectiveness of these treatments represents a major gap in the literature. The proposed study will compare the effectiveness of two leading PTSD treatments - Prolonged Exposure (PE) therapy and pharmacotherapy with paroxetine or venlafaxine extended release - as well as the combination of PE and medication. In a randomized clinical trial, veterans with PTSD (N = 450) recruited across six Veterans Affairs Medical Centers will complete assessments at baseline, mid-treatment (Week 7), post-treatment (Week 14), and follow-up (Weeks 27 and 40). The primary outcome will be change in (both clinician-rated and self-reported) PTSD severity. Depression symptoms, quality of life, and functioning will also be measured and examined as secondary outcomes. Baseline demographic and clinical data will be used to develop "personalized advantage indices" (PAIs), with the goal of identifying who is most likely to benefit from which treatment. This planned trial will yield findings to directly inform clinical practice guidelines for PTSD, by providing comparative effectiveness data to support recommendations about what can be considered the "first-line" treatment option(s) for PTSD. Further, findings from this trial have the potential to guide treatment planning for individual patients, through implementation of PAIs developed from study data, in service of "personalized medicine." https://clinicaltrials.gov/ct2/show/NCT04961190.